Background: The CYP19A1 enzyme (aromatase) encoded by the cytochrome P450 (CYP) 19A1 gene influences the final step in the biosynthesis of estrogen, which has been associated with Alzheimer disease (AD). It is possible that genetic polymorphisms in CYP19A1 could influence the risk of AD by altering the expression of CYP19A1. The ε4 allele of the apolipoprotein E (APOE) gene, which is the most significant known genetic risk factor for AD, may mask the effects of other loci.
Methods: To assess the potential association of CYP19A1 gene polymorphisms with the risk of AD, we conducted a case-control study in a Chinese Han population by recruiting 463 cases, including 207 patients diagnosed with AD and 256 healthy people matched for sex and age.
Results: In APOE ε4 carriers, the distributions of the G allele and the AG + GG genotype of CYP19A1 rs3751592 in patients differed significantly (P < 0.05) from those in healthy people. However, no difference was observed in the distribution of CYP19A1 rs1065778 between the patient and control populations, regardless of their APOE ε4 status.
Conclusion: The results demonstrated that the rs3751592 A/G polymorphism of the CYP19A1 gene was associated with the incidence of AD in a Chinese Han population, which suggests that CYP19A1 rs3751592 is a predisposing genetic factor for AD.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008603 | PMC |
http://dx.doi.org/10.1097/MD.0000000000004742 | DOI Listing |
Pharmgenomics Pers Med
May 2023
Department of Cardiology, Haikou People's Hospital, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, Hainan, 570100, People's Republic of China.
Introduction: Ischemic stroke (IS) is a multifactorial and polygenic disease, which is affected by genetic factors. In this study, we explored the role of single nucleotide polymorphisms (SNPs) in IS in the Chinese population.
Methods: 1302 subjects (651 controls and 651 cases) were recruited in this case-control study.
World J Surg Oncol
December 2022
Department of Hematology, The First People's Hospital of Yunnan Province, Xishan District, #157 Jinbi Road, Kunming, 650032, Yunnan, China.
Background: Lung cancer is the leading cause of cancer death globally. Recent studies have revealed that CYP19A1 gene plays a crucial role in cancer initiation and development. The aim of this study was to assess the association of CYP19A1 genetic polymorphisms with the risk of lung cancer in the Chinese Han population.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2016
Southern Medical University Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command Center for Disease Control and Prevention of Guangzhou Military Command, Guangzhou, China.
Background: The CYP19A1 enzyme (aromatase) encoded by the cytochrome P450 (CYP) 19A1 gene influences the final step in the biosynthesis of estrogen, which has been associated with Alzheimer disease (AD). It is possible that genetic polymorphisms in CYP19A1 could influence the risk of AD by altering the expression of CYP19A1. The ε4 allele of the apolipoprotein E (APOE) gene, which is the most significant known genetic risk factor for AD, may mask the effects of other loci.
View Article and Find Full Text PDFHum Reprod
May 2012
Oslo and Akershus University College of Applied Sciences, St. Olavs plass, NO-0130 Oslo, Norway.
Background: Testicular germ cell tumour (TGCT) is the most common cancer in young men, and an imbalance between the estrogen and androgen levels in utero is hypothesized to influence TGCT risk. Thus, polymorphisms in genes involved in the action of sex hormones may contribute to variability in an individual's susceptibility to TGCT.
Methods: We conducted a Norwegian-Swedish case-parent study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!